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Abstract: Our aim was to investigate if neonatal bilateral administration of lidocaine into the 
ventral hippocampus would cause behavioral changes related to schizophrenia. A neonatal 
ventral-hippocampal lesion (nVH lesion) was made with lidocaine in Wistar male pups. Two 
groups were formed, the ﬁ  rst received lidocaine (4 μg/0.3 μL) and the second an equal volume 
of vehicle. At day 35 and 56, both groups were tested for social contact, immobility caused by 
clamping the neck and dorsal immobility, locomotor activity in an open ﬁ  eld, and tail ﬂ  ick (TF) 
latency after a painful heat stimulus. All animals were then killed. Coronal cuts (7 μm) of the 
brain were obtained and each brain section was stained with cresyl violet-eosin. The animals 
which received the nVH lesion with lidocaine had decreased social interaction at both ages. 
The rats with lesions, only at day 58 postnatal, increased their distance traveled and ambulatory 
time, with a decrease in their nonambulatory and reset time. The rats with lesions had a longer 
duration of immobility caused by clamping the neck and a longer dorsal immobility at both days 
34 and 57 compared to control rats. The lidocaine-treated group spent less time to deﬂ  ect the 
tail compared to the control group at postpubertal age. The neonatal bilateral administration of 
lidocaine into the ventral hippocampus caused some alterations, such as chromatin condensation, 
nucleolus loss, and cell shrinkage, but glial proliferation was not seen. Neonatal bilateral lidocaine 
administration into the ventral hippocampus caused postpubertal behavioral changes.
Keywords: lidocaine, hippocampus, neonatal lesion, behavior, animal model, psychopatho-
logical disorders
Introduction
Lidocaine is a local anesthetic widely used in the clinic because of the blockade of 
sodium inﬂ  ux in nociceptive ﬁ  bers. High lidocaine doses have been shown to be toxic 
because it can cause the cauda equina syndrome and transient neurological symptoms 
after spinal anesthesia.1 It also produces sedation, tremulousness, and dysphoria in 
humans.2 Studies of the central nervous system of the rat show that lidocaine activates 
limbic structures such as the hippocampus and amygdale3 and causes neuronal damage 
in those structures.4
Both the amygdala and hippocampus are implicated in psychiatric disorders as 
autism,5 attention-deﬁ  cit hyperactivity,6 and schizophrenia.7–9
Many epidemiological and clinical correlation studies show that obstetric complica-
tions, in utero exposure to ethanol, severe malnutrition, and viral infection are risk factors 
for the development of schizophrenia.10,11 It has been hypothesized that schizophrenia is Neuropsychiatric Disease and Treatment 2009:5 16
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a disease related to abnormal neurodevelopment of cortical and 
subcortical circuitry in which the amygdala and hippocampus 
participate.10,12
Rats with an ibotenic acid-caused neonatal excitotoxic-
lesion in the ventral hippocampus show, in adulthood, a 
variety of behavioral abnormalities, such as a deﬁ  cit in the 
prepulse inhibition of startle,13 latent inhibition,14 impaired 
social behavior,15 working memory deﬁ  cit,16 hyperlocomo-
tion in an open-ﬁ  eld test,17 high immobility response caused 
by clamping the neck,18 and hyperalgesia.19 All these behav-
iors show parallels to schizophrenia. However, the neonatal 
excitotoxic-lesion with ibotenic acid causes gliosis, a process 
absent in schizophrenic patients.8 The aim of our work was 
to investigate if the neonatal bilateral administration of 
lidocaine into the ventral hippocampus caused behavioral 
changes related to schizophrenia.
Material and methods
Animals and housing
All animal procedures were done in accordance with the 
guidelines of the Laws and Codes of Mexico in The Seventh 
Title of the Regulations of the General Law of Health 
Regarding Health Research.
The neonatal ventral-hippocampal lesions (nVH lesion) 
with lidocaine were made in Wistar male pups on day 7 when 
the pups weighed 15–17 g. The neonatal administration was 
made as described previously.20 Brieﬂ  y, pups were anaesthe-
tized by hypothermia and immobilized in a stereotaxic frame. 
To enable stable ﬁ  xation of the head a silicone mould was 
constructed into which rat pups of a speciﬁ  c head size ﬁ  t. 
A midline skin incision was made, the skull was perforated 
using a 1.0 mm dental drill, and lidocaine (4 μg/0.3 μL over 
2 min) (n = 8) or vehicle (0.1 M phosphate-buffered saline, 
pH 7.4) (n = 8) was injected bilaterally through 0.33 mm 
stainless steel cannula into the ventral hippocampus (coor-
dinates: AP −3.0 mm, ML ± 3.5 mm, DV −5.0 mm relative 
to Bregma). Subsequently, the skin was stitched and the 
animals were returned to their nurse.
Behavioral procedure
All behavioral testing was done between 9 am and 12 pm 
and was recorded on videotape using a VHS video camera 
(NV-N3000PN, Panasonic).
Because it is known that signs and symptoms of schizo-
phrenia emerge after puberty, we analyzed the behavioral test at 
both prepuberal (P33–P35) and postpuberal (P56–58) ages.
On days 33 and 56, rats were brought, in individual plastic 
cages, to the testing area, which was in the same building 
and ﬂ  oor as the colony room. Two animals from the same 
experimental group were placed in the testing area and ten 
minutes of their social interaction was videotaped and auto-
matically analyzed by the Videomex V apparatus (Colum-
bus Instruments, Columbus, OH). After each trial, the rats 
were returned to the colony room and the area was cleaned 
with a detergent. The test time of day was balanced across 
experimental groups.
On days 34 and 57, the animals were tested for immobility 
caused by clamping the neck and dorsal immobility.
On days 35 and 58, rats were brought, in individual plastic 
cages, to the testing area. An animal was placed on the open 
ﬁ  eld for six minutes and locomotor behavior was recorded 
every three minutes. After this, tail ﬂ  ick (TF) latency after a 
painful heat stimulus was recorded. There were three minutes 
between each test on each animal.
When the behavioral test was completed, the rat was 
returned to the colony room and the work area was cleaned 
with a neutral detergent. The test time of the day was bal-
anced across the experimental groups.
Behavioral testing
Social contact test (P33 and P56)
The general design was adapted from Rex.21 Twenty-four 
hours before the testing, animals were singly housed in a 
metallic cage (20 × 30 × 18 cm) with food and water ad 
libitum. The cages were located together in racks to maintain 
auditory and olfactory contact. The test was made in an open 
arena (60 × 60 × 30 cm). The ﬂ  oor was made of smooth black 
wood. The light conditions were comparable to the light 
intensity in the housing room; two 39-W overhead ﬂ  uorescent 
bulbs were suspended 180 cm above the center of the ﬁ  eld 
and provided 210 Lx at the ﬂ  oor. The social behavior was 
measured using a video image analyzer (Videomex-V) over 
ten minutes. The social contact program provides a simple 
method for recording the interaction between two animals. 
It gives the total number of contacts during the experiment 
and the total time the animals have been in contact.
Immobility induced by clamping 
the neck (P34 and P57)
The immobility response was made by attaching a clamp 
(a 5-cm alligator clip with its tips covered with masking 
tape to avoid any injury to the rat’s skin) between the base 
of the skull and the back of ears with the pressure being 
sufﬁ  cient to lift the whole animal by the clamp. A second 
clamp was attached to the ventral part of the neck to increase 
the pressure in this area. The animal was then inverted into Neuropsychiatric Disease and Treatment 2009:5 17
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a supine position. The duration of immobility was measured 
from the time the animal was placed on its back until it recov-
ered the prone position or until 180s had elapsed.18,22
Dorsal immobility (P34 and P57)
The animal was gently grasped by the skin at the back of the 
neck and lifted off its feet 30–40 cm over the experimental 
table, avoiding disturbing the animal’s breathing and using 
only enough pressure to lift the whole rat body. When ani-
mal stopped moving, the time of immobility was recorded 
until the animal made escape-like movements directed at the 
experimenter’s hand or until 180s had elapsed.22
Open-ﬁ  eld test in an unknown environment 
(P35 and P58)
This test has been regularly used to assess emotion in 
rodents.23 The animal was transferred to the testing room and 
immediately placed on the middle of the open ﬁ  eld (black-
painted wooden box, 60 × 60 × 30 cm). The light conditions 
were comparable to the social contact test. The spontaneous 
locomotor activity in an unfamiliar environment was mea-
sured using a video image analyzer in two sessions of three 
min each. This keeps track of the distance the animal travels, 
the amount of time spent traveling, the amount of time spent 
in a nonambulatory activity, and the amount of time resting. 
It also displays the path tracings during the session.
Nociceptive test (P35 and P58)
The tail ﬂ  ick (TF) test was made using restraining tubes 
constructed from Plexiglas pipe (6.3 × 20 cm) with circular 
Plexiglas lids attached to the ends. Small holes were drilled 
in the front and sides of the tubes to provide adequate ventila-
tion. TF latencies were measured using a tail ﬂ  ick apparatus 
(Columbus Instruments, Columbus, OH) that delivers radiant 
heat. The light source positioned below the tail was focused 
on the proximal third of the rat’s tail. Deﬂ  ection of the tail 
activated a photocell and automatically terminated the trial. 
The TF latency represents the period of time from the begin-
ning of the trial to the tail deﬂ  ection. A cut-off time of 30s 
was used to prevent tissue damage.
Brain histology
All animals were anesthetized with sodium pentobarbital 
(35 mg/kg ip) 48-h after the testing day and they were 
transcardially perfused, ﬁ  rst with 0.9% saline and then with 
10% formaldehyde. The brains were removed and were embed-
ded in parafﬁ  n. Coronal cuts of 7 μm were obtained from 
−1.8 to −4.8 mm from Bregma.24 Each brain section was stained 
with cresyl violet-eosin, dehydrated, and mounted with resin.
Statistical analysis
All results are presented as mean ± SE. Statistical analysis 
for all behavioral tests was evaluated by two-way ANOVA, 
Student’s t-test, and a post hoc Newman-Keuls. The two fac-
tors evaluated in ANOVA were age and treatment. P  0.05 
was considered statistically signiﬁ  cant.
Results
Social contact test
Figure 1 shows that animals that received the nVH lesion 
with lidocaine had decreased social interaction at two ages 
(panel A, between age F1,12 = 1.20, P = 0.30; between 
treatment F1,12 = 59.05, P  0.0001; and interaction age × 
treatment F1,12 = 0.04, P = 0.85) without affecting the num-
ber of contacts (panel B, between age F1,12 = 1.43, P = 0.25; 
between treatment F1,12 = 0.03, P = 0.87; and interaction 
age × treatment F1,12 = 0.01, P = 0.91).
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Figure 1 Effect of neonatal bilateral administration of lidocaine into the ventral hippocampus on social contact time (A) and contact number (B) in 10 minutes of behavioral test.
Note: *P  0.05 vs control group at the same age.Neuropsychiatric Disease and Treatment 2009:5 18
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Immobility responses
Immobility responses were modiﬁ  ed after the nVH lesion 
with lidocaine. Thus, panel A of Figure 2 shows that rats 
with lesions had a longer duration of immobility caused 
by clamping the neck at both 34 and 57 days compared to 
control rats (between age F1,28 = 8.31, P  0.009; between 
treatment F1,28 = 18.36, P  0.001; and interaction age × 
treatment F1,28 = 1.55, P = 0.23). Also, panel B of ﬁ  gure 2 
shows that treated rats had higher dorsal immobility in both 
ages (between age F1,28 = 8.44, P  0.01; between treatment 
F1,28 = 23.16, P  0.001; and interaction age × treatment 
F1,28 = 1.884, P  0.05).
Open-ﬁ  eld test
Figure 3 shows how the nVH lesion with lidocaine affects the 
variables of the open-ﬁ  eld test such as the distance traveled 
(between age F1,28 = 15.98, P  0.001; between treatment 
F1,28 = 5.85, P  0.025; and interaction age × treatment 
F1,28 = 2.45, P = 0.13), reset time (between age F1,28 = 10.19, 
P  0.005; between treatment F1,28 = 11.36, P  0.005; and 
interaction age × treatment F1,28 = 2.20, P = 0.15), ambula-
tory time (between age F1,28 = 13.29, P  0.009; between 
treatment F1,28 = 11.31, P  0.005; and interaction age × 
treatment F1,28 = 0.06, P = 0.80), and nonambulatory time 
(between age F1,28 = 1.69, P = 0.20; between treatment 
F1,28 = 5.60, P  0.05; and interaction age × treatment 
F1,28 = 4.15, P = 0.055). It shows that all animals reduced their 
distance traveled at postpubertal age (panel A), whereas rats 
with lesions increased their locomotor activity and distance 
traveled at day 58 compared with its respective control. In 
contrast, reset time is reduced in animals with lesions at post-
pubertal age and increased in control animals at the same age 
(panel B). Animals with lesions spent more time exploring 
and had more ambulatory time at both ages, whereas control 
rats spent less ambulatory time at day 58 (panel C). Panel D 
shows that control animals had less nonambulatory time at 
postpubertal age, whereas rats with lesions had this variable 
enhanced at the same ages.
Tail ﬂ  ick
Figure 4 shows how the nVH lesion lidocaine lesion affects 
tail ﬂ  ick latency (between age F1,28 = 21.69, P  0.001; 
between treatment F1,28 = 5.51, P  0.05; and interaction 
age × treatment F1,28 = 4.19, P  0.05). We saw that age 
increases tail flick latency in all animals, however the 
lidocaine-treated group spent less time to deﬂ  ect the tail 
compared to the control group at postpubertal age.
Brain histology
The brain histology is shown in Figure 5. It shows that the 
nVH lesion with lidocaine yields the dorsal and ventral por-
tion of hippocampus morphologically intact without gliosis 
(panel A). Ampliﬁ  cation of the CA3 hippocampal region 
(panels B and C) shows that control animals have normal 
neurons with a distinguishable nucleus, nucleolus, and a high 
ratio nucleus/cytoplasm (panel B), whereas neonatal bilateral 
administration of lidocaine into the ventral hippocampus 
caused a reduction of neurons with some alterations such as 
chromatin condensation, nucleolus loss, and cell shrinkage, 
but glial proliferation was not seen (panel C).
Discussion
Lidocaine is the most popular of local anesthetics and is 
widely used in the clinic. However, high doses of this drug 
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Figure 2 Effect of neonatal bilateral administration of lidocaine into the ventral hippocampus on durations of immobility caused by clamping the neck (A) and dorsal 
immobility (B).
Note: *P  0.05 vs control group at the same age.Neuropsychiatric Disease and Treatment 2009:5 19
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administrated systemically in adult rats cause adverse effects 
as seizures, asphyxia, tachycardia, and death.2 Post and 
coworkers studying lidocaine-caused kindling demonstrated 
that chronic lidocaine administration causes activation of 
the amygdala and hippocampus,3 which causes seizure and 
behavioral changes related to schizophrenic symptoms.25 
Additionally, our research group demonstrated that one injec-
tion of lidocaine caused selective neuronal damage in the hip-
pocampus and amygdale.4 Moreover, there are many studies 
focusing on neonatal damage of restricted limbic structures 
in rats, thus neonatal excitotoxic lesions of the rat ventral 
hippocampus lead, in early adulthood, to altered behaviors 
that are closer to symptoms present in psychopathological 
diseases. Our objective of this research is to determine if 
the nVH lesion with lidocaine caused behavioral changes in 
Wistar rats by testing social interaction, open-ﬁ  eld activity, 
dorsal immobility responses and that caused by clamping the 
neck, and the tail-ﬂ  ick test.
The social interaction test is a simple protocol that has 
been used in rats to test for anxiety in a novel environment. 
In this work, we found that the lidocaine-treated group 
decreased social interactions at both ages. This ﬁ  nding 
indicates that the nVH lesion with lidocaine altered neuronal 
pathways related to the hippocampus because this structure 
participates in sequences of social behavior (starting, 
stopping, or continuous social contact).26 Our results are in 
concordance with others, though they used an nVH lesion 
caused by ibotenic acid in Sprague-Dowley rats,15 however 
did not ﬁ  nd any postpubertal difference in the social interac-
tion test using Wistar rats that had an ibotenic acid-caused 
neonatal lesion in the VH.27 Reduction in social interaction 
can be related to hypersensitivity to dopamine28 because the 
social behavior of animals is sensitive to dopaminergic and 
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Figure 3 Effect of neonatal bilateral administration of lidocaine into the ventral hippocampus on traveled distance (A), amount of time resting (B), as well as amount of 
ambulatory (C) and nonambulatory (D) time during six minutes of the open-ﬁ  eld test in an unknown environment.
Notes: *P  0.05 vs control group at the same age; +P  0.05 vs same group vs age of 35 days old.
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Figure 4 Effect of neonatal bilateral administration of lidocaine into the ventral 
hippocampus on tail ﬂ  ick latency during nociceptive test.
Notes: *P  0.05 vs control group at the same age; +P  0.05 vs same group vs 
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glutamatergic manipulation caused by D1 and D2 agonists, 
and phencyclidine.29
In nature, the immobility response is part of an antipreda-
tory behavior and is used by prey to reduce the probably of 
predator attacks. Experimentally, immobility responses can 
be produced in the laboratory where they can be caused by 
fear or by using a dopamine antagonist (such as haloperidol). 
The immobility caused by clamping the neck and dorsal 
immobility were enhanced in animals with an nVH lesion 
with lidocaine evaluated at the two ages. Though Flores 
and coworkers made lesions in Sprague-Dawley rats, our 
result are in accordance with theirs.18 It is possible that 
activation of a dopaminergic mesolimbic pathway, which 
arrives at the accumbens nucleus from the ventral tegmental 
area (VTA), modiﬁ  es the duration of immobility responses 
because the animals with higher locomotor response to a 
novel environment increase the basal ﬁ  ring and bursting 
activity of dopaminergic neurons in the VTA.30 In addition, 
immobility responses are keen behavioral tests that show 
a general idea of the status of the dopaminergic system 
since the prepuberal age, because immobility responses are 
modulated by structures such as the basal nuclei and nucleus 
accumbens.22,31
The open-ﬁ  eld test in an unknown environment is another 
test to evaluate emotion in rats. We found that the nVH 
lesion with lidocaine causes an increase of the distance trav-
eled because reset time decreased and both ambulatory and 
nonambulatory times are enhanced. Again, these results are 
in accordance with those obtained in the heuristic model of 
schizophrenia,10,17 but not in accordance with results obtained 
using Wistar rats with an nVH lesion with ibotenic acid.32 
The nVH lesion affects dopaminergic afferences to the pre-
frontal cortex, which increases locomotor activity in a novel 
environment at P58 and is related to a higher anxiety level.33 
Moreover, the nVH lesion causes a corticolimbic-pathway 
hyperactivity that increases locomotor activity caused by 
dopamine release in the nucleus accumbens.34
Another test in our model was the latency tail ﬂ  ick. We 
found that lidocaine only modiﬁ  es this response at day 56. 
These results are in accord with results obtained in Sprague-
Dowley rats with neonatal lesions made with ibotenic acid.19 
Dopamine is involved in a nociception mechanism35 and 
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Figure 5 Photomicrographs of coronal section through the brains of animals which had neonatal bilateral administration of lidocaine into the ventral hippocampus (A and C) and 
control animals (B). Panel A shows that lidocaine-treated animals had the dorsal and ventral portion of hippocampus morphologically intact without gliosis. When we ampliﬁ  ed 
the CA3 hippocampal region (B and C) we observed that control animals (B) had normal morphology represented by neurons with distinguishable nucleus, nucleolus, and a 
high ratio of nucleus/cytoplasm (arrows in B demonstrated normal neuron of this region), whereas neonatal bilateral administration of lidocaine into the ventral hippocampus 
caused a mild reduction of neurons with some alterations such as chromatin condensation, nucleolus loss, and cell shrinkage, but no observed glial proliferation (arrows in C 
demonstrated alterations).
Note: Bar in A represents 250 μm and bars in B and C represent 50 μm.Neuropsychiatric Disease and Treatment 2009:5 21
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our model and heuristic models of schizophrenia modify 
the dopaminergic system related to nociception. There are 
several studies of the functional role of basal nuclei in the 
somatosensorial information process about thermal pain 
stimulus.36 There is evidence that a change in pain experi-
ence occurs in conjunction with certain psychiatric disorders. 
However, the results found in the neonatal administration of 
lidocaine to the ventral hippocampus in Wistar rats and in the 
heuristic model of schizophrenia has demonstrated several 
alteration ﬁ  ndings opposite to “schizophrenic analgesia”.37
The morphological study reveals that neonatal lidocaine 
administration in the ventral hippocampus causes a reduction 
of normal morphological neurons in the CA3 hippocampal 
region. These results suggest that the lidocaine dose used 
in this study causes damage. We previously proposed that 
lidocaine causes cytotoxicity by NMDA-receptor activation38 
in limbic structures as the hippocampus and amygdala.4 
The lidocaine dose used by us is higher than when used as a 
sodium-channel blocker.39,40 Moreover, the nVH lesion made 
with lidocaine did not cause gliosis as shown in postmortem 
studies of schizophrenic patients.8
All behavioral tests in this study and the morphological 
evidences support the idea that an nVH lesion caused by 
lidocaine in Wistar rats could be a novel model for a neuro-
developmental hypothesis to study schizophrenia.
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